NCT06874530View on ClinicalTrials.gov

Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions

Multiple Mieloma

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER